BJA Advance Access originally published online on February 20, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
British Journal of Anaesthesia, 2004, Vol. 92, No. 4 469-474
© 2004 The Board of Management and Trustees of the British Journal of Anaesthesia
Clinical Investigations |
Comparison of phenylephrine infusion regimens for maintaining maternal blood pressure during spinal anaesthesia for Caesarean section
Department of Anaesthesia and Intensive Care, The Chinese University of Hong Kong,Prince of Wales Hospital, Shatin, Hong Kong, China
*Corresponding author. E-mail: warwick@cuhk.edu.hk 
This article is accompanied by Editorial I.Presented as a poster at the Australian Society of Anaesthetists and the New Zealand Society of Anaesthetists Combined National Scientific Congress, Melbourne, Australia, October 2–5, 2003.
Background. During spinal anaesthesia for Caesarean section, the optimal phenylephrine regimen and the optimal blood pressure (BP) to which it should be titrated are undetermined. The ideal regimen would balance efficacy for maintaining uteroplacental perfusion pressure against potential for uteroplacental vasoconstriction, both of which may affect fetal acid–base status. We compared phenylephrine infusion regimens based on three different BP thresholds.
Methods. After intrathecal injection, we infused phenylephrine 100 µg min–1 for 2 min. Then, until delivery, we infused phenylephrine whenever systolic BP (SBP), measured every 1 min, was below a randomly assigned percentage of baseline: 100% (Group 100, n=25), 90% (Group 90, n=25) or 80% (Group 80, n=24). We compared umbilical blood gases, Apgar scores and maternal haemodynamics and symptoms.
Results. Patients in Group 100 had fewer episodes [median 0 (range 0–8)] of hypotension (SBP <80% baseline) compared with Group 80 [5 (0–18)] and Group 90 [2 (0–7)] (P<0.001 in each instance). Total dose of phenylephrine was greater in Group 100 [median 1520 µg (interquartile range 1250–2130 µg)] compared with Group 90 [1070 (890–1360) µg] and Group 80 [790 (590–950) µg]. Umbilical arterial pH was greater in Group 100 [mean 7.32 (95% confidence interval 7.31–7.34)] than in Group 80 [7.30 (7.28–7.31)] (P=0.034). No patient had umbilical arterial pH <7.2. In Group 100, 1/24 (4%) patients had nausea or vomiting compared with 4/25 (16%) in Group 90 and 10/25 (40%) in Group 80 (P=0.006).
Conclusions. For optimal management, phenylephrine should be titrated to maintain maternal BP at near-baseline values.
Br J Anaesth 2004; 92: 469–74
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. B. Sartain, J. J. Barry, P. W. Howat, D. I. McCormack, and M. Bryant Intravenous oxytocin bolus of 2 units is superior to 5 units during elective Caesarean section Br. J. Anaesth., December 1, 2008; 101(6): 822 - 826. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. D. Ngan Kee, A. Lee, K. S. Khaw, F. F. Ng, M. K. Karmakar, and T. Gin A Randomized Double-Blinded Comparison of Phenylephrine and Ephedrine Infusion Combinations to Maintain Blood Pressure During Spinal Anesthesia for Cesarean Delivery: The Effects on Fetal Acid-Base Status and Hemodynamic Control Anesth. Analg., October 1, 2008; 107(4): 1295 - 1302. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Balki, S. Kasodekar, S. Dhumne, and J. C. A. Carvalho Prophylactic Granisetron Does Not Prevent Postdelivery Nausea and Vomiting During Elective Cesarean Delivery Under Spinal Anesthesia Anesth. Analg., March 1, 2007; 104(3): 679 - 683. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Erkinaro, T. Kavasmaa, M. Pakkila, G. Acharya, K. Makikallio, S. Alahuhta, and J. Rasanen Ephedrine and phenylephrine for the treatment of maternal hypotension in a chronic sheep model of increased placental vascular resistance Br. J. Anaesth., February 1, 2006; 96(2): 231 - 237. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. G. M. Aya, N. Vialles, I. Tanoubi, R. Mangin, J.-M. Ferrer, C. Robert, J. Ripart, and J.-E. de La Coussaye Spinal Anesthesia-Induced Hypotension: A Risk Comparison Between Patients with Severe Preeclampsia and Healthy Women Undergoing Preterm Cesarean Delivery Anesth. Analg., September 1, 2005; 101(3): 869 - 875. [Abstract] [Full Text] [PDF]
|
|